Stories | Amgen

Multispecifics and Modalities

SCIENCE & INNOVATION 11.28.2023

Any Target, Every Time

PATIENTS 02.07.2023

8 Things to Know About Lipoprotein(a)

teneobio_illo_360x244

SCIENCE & INNOVATION 01.14.2022

Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen

r00.01_MurielleVeniantEllison_360x244

SCIENCE & INNOVATION 11.23.2021

In a First for Industry, Murielle Veniant-Ellison Honored With 2022 Havel Lectureship

website banner 360x244

SCIENCE & INNOVATION 10.21.2021

Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multispecifics can Usher in the Next Wave of Drug Discovery

best_of_cell-tile

SCIENCE & INNOVATION 01.07.2021

Amgen Paper Selected for Best of Cell, a Rare Honor for Industry Scientists

tile-bite-desktop

SCIENCE & INNOVATION 12.04.2020

BiTE^® Technology 101: Learn the What, How, Who and Why of Amgen’s Innovative BiTE Immuno-Oncology Platform

science-cartoon-tile-desktop

SCIENCE & INNOVATION 10.06.2020

Undruggable Targets Meet Their Match in New Amgen Science Cartoon

ray-tile-desktop

SCIENCE & INNOVATION 09.28.2020

Amgen Hosts Live Fireside Chat on New Age of Multispecific Medicines

Antibodies-360

SCIENCE & INNOVATION 08.24.2020

10 Things to Know About Antibodies

SCIENCE & INNOVATION 08.21.2020

A Story of Scientific Serendipity

SCIENCE & INNOVATION 04.22.2020

Highlights from Amgen and Adaptive Biotechnologies Webinar on Research to Find New Antibody Treatment for COVID-19